2024 has been a transformative year for Xiretsa, filled with exciting milestones and promising opportunities. As we continue to tackle the global challenge of antimicrobial resistance (AMR), we would like to share some of the [...]
More news
Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways [...]
November 1st, 2023 - INCATE (the INCubator for Antibacterial Therapies in Europe) and BIOASTER, the [...]
The Entrepreneurs Club is back! Join this 3rd INCATE Entrepreneurs Club on "Creative Funding - [...]
Nijmegen, 12th September 2023 - By the occasion of the World Sepsis Day, SurvivX is [...]
The next INCATE's Selection Committee is coming up and we are now accepting applications for [...]
2023 has reached its final quarter and there are still quite a number of events [...]
6th September 2023 - INCATE (the INCubator for Antibacterial Therapies in Europe) has successfully reached [...]
INCATE PRESS RELEASE 08, May 2023 For immediate release INCATE has selected Invitris as the [...]
